ELDERPHARM

Elder Pharmaceuticals Limited has submitted to the Exchange a copy of disclosure under Regulation 8A (4) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulation 1997. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements) <a href=/content/corporate/Elder_Pledge_13022009.zip target=NEW> For more details click here.</a>

Elder Pharmaceuticals Limited has informed the Exchange that "The Company has entered into an agreement with M/s Daiwa Pharmaceuticals Co. Ltd. of Japan for manufacturing and marketing of some of their products in India. M/s. Daiwa Pharmaceuticals specializes in health supplements and functional foods and their products are well accepted in more than 42 countries. We propose to initially launch in the Indian market "IMBRAN", a novel nutritional supplement for immunity enhancement".

Elder Pharmaceuticals Limited has informed the Exchange regarding the Outcome of Annual General Meeting of the Shareholders of the Company held on September 30, 2008. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/Elder_outcomeofagm_30092008.zip target=NEW> For more details click here.</a>

Elder Pharmaceuticals Limited has submitted to the Exchange the brief summary of the comparative financial results for the years ended on March 31, 2008 and March 31, 2007. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/Elder_26082008.zip target=NEW> For more details click here.</a>

Elder Pharmaceuticals Limited has informed the Exchange that the Board Meeting was held on August 26, 2008 and the following decisions were taken at the said Board meeting: (1) To hold the Annual General Meeting of the Company on September 30, 2008. (2) To recommend for consideration of shareholders' declaration of dividend @ 25%. (3) To keep transfer books closed from September 22, 2008 to September 30, 2008 ( both days inclusive).

Elder Pharmaceuticals Limited has informed the Exchange that at the Board Meeting of the Company held on April 30, 2008 the Board decided to issue and allot 65320 shares to the employees under Elder ESOP 2004 upon exercise options by them as per the scheme. The paid-up share capital now stands increased to Rs.188,574,860/-.

Elder Pharmaceuticals Limited has informed the Exchange that the Board of Directors of the Company met today i.e. March 27, 2008 for discussing 1) alignment of business in two broad heads, namely Pharmaceuticals and Consumer Products Division and 2) merger of Elder Projects Limited with the Company. In view of the implications and impact of certain recent budget notifications on Central excise duty on pharmaceutical products, as interpreted and clarified now, which would not currently render any strategic advantage to the Company, it has been decided by the Board not to go ahead with the propo

Elder Pharmaceuticals Limited has informed the Exchange that: "The Shareholders of our Company had, at the 24th Annual General Meeting held on 27th September 2007 passed a resolution approving raising of funds through an issue of Foreign Currency Convertible Bonds/ GDRs to the extent of US Dollars 50 million. The Company had engaged the Royal Bank of Scotland, Plc and ICICI Bank to act as Placement Agents for a proposed offering of Foreign Currency Convertible Bonds (FCCBs) upto an amount of US Dollars 30 million which were required to be listed on the Singapore Stock Exchange. In pursuance of

Elder Pharmaceuticals Limited had informed the Exchange that the Company was seeking to raise funds through an issue of Foreign Currency Convertible Bonds/GDRs to the extent of US Dollars 50 million. The Company has now informed the Exchange that: "Our Company had in August 2007 engaged the Royal Bank of Scotland Plc and ICICI Bank to act as Placement Agents for a proposed offering of Foreign Currency Convertible Bonds (FCCBs) upto an amount of US Dollar 30 million which were required to be listed on the Singapore Stock Exchange. In pursuance of the engagement of the Placement Agents, our Com

Elder Pharmaceuticals Limited has informed the Exchange that at the Board Meeting of the Company held on January 29, 2008 the Board decided to issue and allot 70586 shares to the employees under Elder ESOP 2004 upon exercise options by them as per the scheme. The paid-up share capital now stands increased to Rs.187,921,660/-.

Elder Pharmaceuticals Limited has informed the Exchange that: "We have entered into a licensing agreement with an Italy based research oriented biotech company by the name GNOSIS S.p.A. for marketing and distribution of an anti-arthritic product, S-Adenosyl-L-Methionine Disulphate p-Toluensulfonate (SAMe) in India".

Elder Pharmaceuticals Limited has informed the Exchange that the Board, in its meeting held on October 30, 2007, amongst other matters, also decided to issue and allot 71916 shares to the employees under Elder ESOP 2004.

Elder Pharmaceuticals Limited has informed the Exchange regarding the outcome of the Annual General Meeting of the Company held on September 27, 2007. The details of the business transacted at the AGM shall be available on the NSE website (http://www.nseindia.com) under Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/ELDERPHARMA_AGM_27092007.zip target=NEW> For more details click here.</a>

Elder Pharmaceuticals Limited has informed the Exchange that the following decisions were taken at the Board Meeting held on August 28, 2007: 1) To hold the Annual General Meeting of the Company on September 27, 2007. 2) To recommend for consideration of shareholders' declaration of dividend @25%. 3) To keep transfer books closed from September 20, 2007 to September 27, 2007 (Both days inclusive). 4) To make 51% acquisition in Biomeda Group of Bulgaria. 5) To appoint subject to the approval of Shareholders, Mr. Yusuf Karim Khan as an Additional Director and Executive Director for a period of f

Elder Pharmaceuticals Limited has informed the Exchange that the Company has finalized a 20% strategic stake in Neutra Health PLC. an AIM listed company in the United Kingdom. This entails an investment of Sterling Pounds 5.63 million (approximately Rs.46-47 crores) in respect of 35197026 equity shares having a face value of 10 pence at 16 pence per share. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/Elder_PR_26072007.zip ta

Elder Pharmaceuticals Limited has informed the Exchange that amongst other matters, the Board at their meeting held on July 24, 2007 decided to issue and allot 77926 shares to the employees under Elder ESOP 2004 upon exercise of options by them as per the Scheme".

Elder Pharmaceuticals Limited has informed the Exchange that at the Board Meeting of the Company held on July 24, 2007, the Board decided to accept the resignation of Mr. V.N. Paranjpe as Joint Managing Director. The Board also decided to raise funds through ECB and/or issuance of FCCBs upto an amount of 50 Million US dollars for acquisition opportunities/capex and authorized the Managing Director to take necessary steps and actions thereon including convening of Extra Ordinary General Meeting.

Elder Pharmaceuticals Limited has informed the Exchange that "The Company has entered into an agreement with Cymbiotics of USA for in-licensing arrangement for marketing of their pharmaceutical formulation for Diabetes, Chronic Pain, Skin Care, etc".

Elder Pharmaceuticals Limited has informed the Exchange that at the Board meeting held on April 24, 2007 the Board considered and gave its in principle approval to the FCCB issue of upto USD 50 million.

Elder Pharmaceuticals Limited has informed the Exchange that "the Company has entered into an agreement with Laboratorios Farmaceuticos Rovi, S.A. of Spain for marketing their drug for treatment and prevention of thrombo-embolic Venous diseases like deep vein thrombosis and pulmonary embolism. Further, the Company has submitted a press release titled "Elder Pharmaceuticals enters into Alliance with Laboratorios Farmaceuticos Rovi, S.A of Spain for Anti Thrombotics". A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and o

Elder Pharmaceuticals Limited has informed the Exchange on December 14,2006 that: "The Company has entered into an agreement for marketing of an Osteoporosis drug 'BONVIVA' manufactured by F Hoffmann La Roche Ltd., Basle, Switzerland with their distributors for India, viz. Taksal. The launch of said product is being annunced today and a press conference is being held today in Mumbai on the occasion". Further, a copy of the press release, titled �Roche Osteoporosis Bonviva to be marketed by Elder Pharmaceuticals in India� shall be available on the NSE website (http://www.nseindia.com) under:

Elder Pharmaceuticals Limited has informed the Exchange that at a meeting of the Board of Directors held on November 27, 2006 the Directors have allotted 6,00,000 Equity Shares of Rs. 10/- each (fully paid-up) to the following allottees upon them exercising equal number of warrants allotted to them last year. The paid-up share capital thus stands increased to Rs.185,717,380/-. ACRAF S.p.A. - 1,50,000. Citicorp International Finance Corporation - 4,50,000.

News Verification : The media had reports that Elder Pharmaceuticals Limited is in final stages of acquiring a medium scale generic company in UK. The Exchange, in order to verify the accuracy or otherwise of the information reported in the media and to inform the market place so that the interest of the investors is safeguarded, had written to the officials of the company. Elder Pharmaceuticals Limited has vide its letter inter-alia stated, "As of now there are no plans of acquiring any Company in UK. However, in future whenever there is any plan, we will inform the Exchange accordingly."

Elder Pharmaceuticals Limited has submitted to the Exchange a copy of the minutes of the AGM of the Company held on September 29,2006. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/ElderPharm_AGM_08112006.zip target=NEW> For more details click here.</a>

Elder Pharmaceuticals Limited has informed the Exchange that a meeting of the Board of Directors of the Company was held on September 29,2006. It was decided at the said meeting to appoint Mr. Michael Bastian as an Additional Director on the Board from September 29,2006.

Elder Pharmaceuticals Limited has informed the Exchange that the Annual General Meeting of the shareholders of the Company was held on September 29, 2006 and amongst others the following resolutions were passed:- (i) for declaration of dividend @ 25% for the year ended March 31, 2006. (ii) for re-appointment of Mr. Peter Charles Bibby as Director whose period of office is liable to retirement by rotation. (iii) for re-appointment of Dr. S. Jayaram as Director whose period of office is liable to retirement by rotation. (iv) for increase in the borrowing powers of the Board of Directors to Rs. 3

Elder Pharmaceuticals Limited has informed the Exchange that at a meeting of the Board of Directors held on September 21, 2006, the Directors have allotted 5,00,000 Equity Shares of Rs. 10/- each (fully paid-up) to Elder Pharma Employees Welfare Trust (EPEWT) upon EPEWT exercising equal number of warrants allotted to it last year. The paid-up share capital thus stands increased to Rs. 179,717,380/-. In the same meeting it was also decided to change the Registrars and Share Transfer agents from existing MCS Ltd. to Intime Spectrum Registry Ltd. The said appointment will take effect immediately

Elder Pharmaceuticals Limited has informed the Exchange that the Company has been able to negotiate a Joint Venture with a local party in Ghana. The Joint Venture Company will manufacture pharmaceutical formulations which will be marketed in Ghana and nearby countries. The Company and the local Ghana party will have equal stake of 50% each in the Joint Venture company. The Joint Venture agreement will be executed in due course of time.

News Verification : The media had reports that Elder Pharmaceuticals Limited may acquire 60% stake in Ghana-based Wincom Pharmaceuticals. The Exchange, in order to verify the accuracy or otherwise of the information reported in the media and to inform the market place so that the interest of the investors is safeguarded, had written to the officials of the company. Elder Pharmaceuticals Limited has vide its letter inter-alia stated, "We would like to inform you that the possibilities of the Joint Venture is being explored for quite some time and this was reported in the Directors Report for th

Elder Pharmaceuticals Limited has informed the Exchange that the Board of Directors in its meeting held on August 25, 2006 has recommended dividend @25%.

Elder Pharmaceuticals Limited has informed the Exchange that the following decisions were taken at the Board meeting held on August 25,2006 : 1) To hold the AGM of the Company on September 29,2006. 2) To keep transfer books closed from September 25,2006 to September 29,2006 (Both days inclusive).

Elder Pharmaceuticals Limited has informed the Exchange that Indarts Exports Pvt. Ltd. has acquired 5000 shares on June 16, 2006; 1,217 shares on June 20, 2006 and 3,000 shares on June 23, 2006 aggregating to 0.047% of the total paid up capital of Elder Pharmaceuticals Limited . The mode of acquisition is through Open Market and the shareholding of Indarts Exports Pvt. Ltd. after the said acquisition is 1853516 shares aggregating to 10.60% of the total paid up capital of Elder Pharmaceuticals Limited.

Elder Pharmaceuticals Limited has informed the Exchange that Indarts Exports Pvt. Ltd. has acquired 3455 shares on June 14,2006 and 12138 shares on June 15,2006 aggregating to 0.079% of the total share capital of Elder Pharmaceuticals Limited . The mode of acquisition is through Open Market and the shareholding of Indarts Exports Pvt. Ltd. after the said acquisition is 1844299 shares aggregating to 10.55% of the total share capital of Elder Pharmaceuticals Limited.

Elder Pharmaceuticals Limited has informed the Exchange that Indarts Exports Pvt. Ltd. has acquired 8412 shares on June 8,2006 and 700 shares on June 9,2006 aggregating to 0.044% of the total share capital of Elder Pharmaceuticals Limited . The mode of acquisition is through Open Market and the shareholding of Indarts Exports Pvt. Ltd. after the said acquisition is 1828706 shares aggregating to 10.46% of the total share capital of Elder Pharmaceuticals Limited.

Elder Pharmaceuticals Limited has informed the Exchange that Indarts Exports Pvt. Ltd. has acquired 10,624 shares aggregating to 0.04% of the total share capital of Elder Pharmaceuticals Limited on June 06, 2006 and acquired 31,481 shares aggregating to 0.18% of the total share capital of Elder Pharmaceuticals Limited on June 07, 2006. The mode of acquisition is through Open Market and the shareholding of Indarts Exports Pvt. Ltd. after the said acquisition is 18,19,594 shares aggregating to 10.41% of the total share capital of Elder Pharmaceuticals Limited.

Elder Pharmaceuticals Limited has informed the Exchange that Indarts Exports Pvt. Ltd. has acquired 10,000 shares aggregating to 0.05% of the total share capital of Elder Pharmaceuticals Limited on May 22, 2006. The mode of acquisition is through Open Market and the shareholding of Indarts Exports Pvt. Ltd. after the said acquisition is 17,77,489 shares aggregating to 10.17% of the total share capital of Elder Pharmaceuticals Limited.

Elder Pharmaceuticals Limited has informed the Exchange that at the meeting of the Board of Directors of the Company held on March 28, 2006 amongst others the following decisions were taken:(1) To purchase, subject to requisite permissions, consents, approvals, etc. if any, an undertaking for manufacture of injectables in liquid oral dosage form of Elder Projects Limited located at Patalganga,District Raigad;(2) To grant Employee Stock Options to the extent of 4,00,000 shares under the Elder ESOP 2004. The Managing Director has been authorized by the board to finalise the documentation in res

Elder Pharmaceuticals Limited has informed the Exchange that there was a search by the Income Tax Department on our Company and at the residential premises of the promoters on March 21 and March 22 , 2006.

Elder Pharmaceuticals Limited has informed the Exchange that Indarts Exports Pvt. Ltd. has acquired 17,000 shares aggregating to 0.09% of the total share capital of Elder Pharmaceuticals Limited on March 10, 2006. The mode of acquisition is through Open Market and the shareholding of Indarts Exports Pvt. Ltd. after the said acquisition is 16,82,349 shares aggregating to 9.62% of the total share capital of Elder Pharmaceuticals Limited.

Elder Pharmaceuticals Limited has informed the Exchange that Citigroup Banking Corporation A/c CBC Bahrain has acquired 125,700 shares aggregating to 0.71% of the total share capital of Elder Pharmaceuticals Limited on March 03, 2006. The mode of acquisition is through Secondary Market Purchase and the shareholding of Citicorp Banking Corporation A/c CBC Bahrain after the said acquisition is 915,588 shares aggregating to 5.22% of the total share capital of Elder Pharmaceuticals Limited.

Citigroup has informed the Exchange that Citigroup Banking Corporation A/c Cbc Bahrain alongwith Pac : Citigroup International Finance Corporation Limited has acquired 1,25,700 shares aggregating to 0.71% of the total paid up capital of Elder Pharmaceuticals Limited on March 03, 2006. The mode of acquisition is through Secondary Market Purchase and the shareholding of Citigroup Banking Corporation A/c Cbc Bahrain alongwith Pac : Citigroup International Finance Corporation Limited after the said acquisition is 9,15,588 shares aggregating to 5.22% of the total paid up capital of Elder Pharmaceut

Elder Pharmaceuticals Limited has informed the Exchange that Indarts Exports Private Limited has acquired shares of Elder Pharmaceuticals Limited as follows: (1) 17,000 shares (0.09%) on March 02, 2006 and (2) 17,000 shares (0.09%) on March 06, 2006. The mode of acquisition is Open Market and the shareholding of Indarts Exports Private Limited after the said acquisition is 1665349 shares aggregating to 9.53% of the share capital of Elder Pharmaceuticals Limited.

Elder Pharmaceuticals Limited has informed the Exchange that Citigroup International Finance Corporation(CIFC) and CBC Bahrain (PAC) has acquired 78,905 shares of the total paid up capital of Elder Pharmaceuticals Limited on March 02, 2006. The mode of acquisition is through Secondary Market Purchase and the shareholding of Citigroup International Finance Corporation and CBC Bahrain (PAC) after the said acquisition is 12,80,000 shares of CIFC and 7,89,888 shares of CBC Bahrain shares aggregating to 11.81% of the total share capital of Elder Pharmaceuticals Limited.

Citibank, N.A. has informed the Exchange that CBC Bahrain and Citigroup International Finance Corporation (PAC) has acquired 78,905 shares of Elder Pharmaceuticals Limited on March 02, 2006. The mode of acquisition is through Secondary Market Purchase and the shareholding of CBC Bahrain and Citigroup International Finance Corporation (PAC) after the said acquisition is 12,80,000 shares of CIFC and 7,89,888 shares of CBC Bahrain shares aggregating to 11.81% of the total share capital of Elder Pharmaceuticals Limited.

Elder Pharmaceuticals Limited has informed the Exchange that Indarts Exports Private Limited has acquired shares of Elder Pharmaceuticals Limited as follows: (1) 25,000 shares (0.143%) on January 24, 2006 and (2) 10,000 shares (0.057%) on January 27, 2006. The mode of acquisition is Open Market and the shareholding of Indarts Exports Private Limited after the said acquisition is 1631349 shares aggregating to 9.33% of the share capital of Elder Pharmaceuticals Limited.

Elder Pharmaceuticals Limited has informed the Exchange that the Company has on January 10, 2006 signed an agreement with Worldwide Media Pvt. Ltd. for allowing the Company to be the Principal Sponsor for the annual FILMFARE Awards and the South FILMFARE Awards for the events to be hosted in the years 2006,2007 and 2008.

Elder Pharmaceuticals Limited has informed the Exchange that the Company is in advanced stage of negotiations with World Wide Media Pvt. Ltd. for allowing the Company to be the Principal Sponsor of the annual FILMFARE Awards and South FILMFARE Awards for the year 2006, 2007 and 2008.

Elder Pharmaceuticals Limited has informed the Exchange that Mr. Adil Saifuddin Kajiji who was a member of the BODs of the Company expired during December 2005.The casual vacancy caused by his death has not yet been filled by the Company.

Elder Pharmaceuticals Limited has submitted to the Exchange a copy of the Minutes of AGM of the shareholders of the Company held on September 27, 2005.The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/CorporateAnnouncements).

Elder Pharmaceuticals Limited has informed the Exchange that they have started commercial production at the Company's new formulation plant at Selaqui, Dehradun, Uttaranchal. The said plant is located at a location notified by the Central Government for central excise exemption and income tax exemption / concession. The Company proposes to set up two more formulation plants, one in Uttaranchal and the other in Himachal Pradesh for which land has already been acquired.